SLC25A29 and neoplasm: In this study, the downregulation of SLC25A29 in tumor tissue and its lower expression in endothelial cells in LUAD tissues compared with adjacent normal tissues were confirmed through various experiments, including RT-qPCR, western blotting, and immunohistochemistry.